VB-111 in Combination With Nivolumab in People With Metastatic Colorectal Cancer (mCRC)
Conditions: Metastatic Colorectal Cancer; Colorectal Neoplasms; Colorectal Carcinoma; Colorectal Cancer With Hepatic Metastases; Colorectal Tumors Interventions: Biological: VB-111; Drug: Nivolumab Sponsor: National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials